We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
Cap. Flow
+$505M
Cap. Flow %
0.65%
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$83.5M
2
SPGI icon
S&P Global
SPGI
+$73.5M
3
TSLA icon
Tesla
TSLA
+$55.8M
4
MSFT icon
Microsoft
MSFT
+$45.9M
5
AMZN icon
Amazon
AMZN
+$27.9M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$88.8M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$74.7M
3
CONE
CyrusOne Inc Common Stock
CONE
+$31.7M
4
ABT icon
Abbott
ABT
+$25.5M
5
EXC icon
Exelon
EXC
+$23.2M

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Financials 13.53%
3 Healthcare 13.01%
4 Consumer Discretionary 11.66%
5 Industrials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLYB icon
2901
Rallybio
RLYB
$85.8M
$91K ﹤0.01%
+1,624
New +$134K
CARM
2902
DELISTED
Carisma Therapeutics
CARM
$90K ﹤0.01%
7,480
+529
+8% +$7.39K
DRIO icon
2903
DarioHealth
DRIO
$71.2M
$90K ﹤0.01%
769
+27
+4% +$4.47K
IMDX
2904
Insight Molecular Diagnostics
IMDX
$156M
$90K ﹤0.01%
3,018
+143
+5% +$4.57K
ACIC icon
2905
American Coastal Insurance
ACIC
$493M
$89K ﹤0.01%
26,809
-2,371
-8% -$8.96K
IMRX icon
2906
Immuneering
IMRX
$292M
$89K ﹤0.01%
+13,819
New +$133K
ATNX
2907
DELISTED
Athenex, Inc. Common Stock
ATNX
$89K ﹤0.01%
5,352
-105
-2% -$2.06K
ICAD
2908
DELISTED
iCAD Inc
ICAD
$88K ﹤0.01%
19,635
+4,159
+27% +$20.9K
PLM
2909
DELISTED
PolyMet Mining Corp.
PLM
$88K ﹤0.01%
20,947
+976
+5% +$2.81K
RGS icon
2910
Regis Corp
RGS
$70.3M
$87K ﹤0.01%
2,051
+306
+18% +$10.7K
LOTZ
2911
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$87K ﹤0.01%
63,157
-9,248
-13% -$17.4K
KRRO icon
2912
Korro Bio
KRRO
$195M
$86K ﹤0.01%
815
-59
-7% -$11.3K
SLDB icon
2913
Solid Biosciences
SLDB
$900M
$86K ﹤0.01%
4,777
-483
-9% -$8.52K
TNXP icon
2914
Tonix Pharmaceuticals
TNXP
$192M
$86K ﹤0.01%
1
– –
HARP
2915
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$86K ﹤0.01%
1,724
+228
+15% +$11.8K
QTNT
2916
DELISTED
Quotient Limited Ordinary Shares
QTNT
$86K ﹤0.01%
1,792
+19
+1% +$1.14K
FORA
2917
DELISTED
Forian
FORA
$85K ﹤0.01%
12,250
+1,397
+13% +$10.3K
PAVM icon
2918
PAVmed
PAVM
$33.9M
$85K ﹤0.01%
144
+2
+1% +$1.49K
SPRY icon
2919
ARS Pharmaceuticals
SPRY
$612M
$85K ﹤0.01%
24,075
+2,833
+13% +$12.3K
CDAK
2920
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$83K ﹤0.01%
+13,218
New +$83K
CNVY
2921
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$83K ﹤0.01%
+12,764
New +$84.2K
CURI icon
2922
CuriosityStream
CURI
$161M
$82K ﹤0.01%
28,398
-2,016
-7% -$8.09K
MBII
2923
DELISTED
Marrone Bio Innovations, Inc.
MBII
$82K ﹤0.01%
75,752
+3,305
+5% +$2.5K
REV
2924
DELISTED
Revlon, Inc.
REV
$82K ﹤0.01%
10,190
-256
-2% -$2.45K
BDTX icon
2925
Black Diamond Therapeutics
BDTX
$112M
$81K ﹤0.01%
29,064
-1,749
-6% -$6.39K
115 116
117
118 119

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
  • RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
  • RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
  • RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
  • RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
  • RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.